Farallon Capital Management LLC Laboratory Corp Of America Holdings Transaction History

Farallon Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $62.1 Million - $79.5 Million	-303,400 Reduced 58.49%	215,314 $44.1 Million
Q2 2022 Aug 15, 2022	BUY	$213.86 - $277.87 $19 Million - $24.6 Million	88,700 Added 20.63%	518,714 $122 Million
Q1 2022 May 16, 2022	BUY	$259.82 - $298.18 $4.12 Million - $4.72 Million	15,845 Added 3.83%	430,014 $113 Million
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $15.8 Million - $18.3 Million	58,298 Added 16.38%	414,169 $130 Million
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $97.8 Million - $110 Million	355,871 New	355,871 $100 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.